Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lynch Casey
Chief Executive Officer at Quince Therapeutics. Filing since 1 Feb 2021.
CIK 0001770783
Company
Date
Role
Action
Shares
Amount
Of holding
QNCX
Quince Therapeutics, Inc.
10 May 2021
Chief Executive Officer
Sold, plan not stated
30,000
$1.04M
3.0%
QNCX
Quince Therapeutics, Inc.
22 Mar 2021
Chief Executive Officer
Sold, plan not stated
30,000
$1.07M
2.9%
QNCX
Quince Therapeutics, Inc.
3 Feb 2021
Chief Executive Officer
Sold, plan not stated
20,000
$860.53K
1.9%
QNCX
Quince Therapeutics, Inc.
2 Feb 2021
Chief Executive Officer
Sold, plan not stated
20,000
$724.10K
1.9%
QNCX
Quince Therapeutics, Inc.
1 Feb 2021
Chief Executive Officer
Sold, plan not stated
20,000
$724.97K
1.8%
5 decisions on file.
